In our latest News and Views: elena_elez and colleagues VHIO explain how a phase 1 trial reveals crosstalk between the MAPK pathway and the immune system, and a new potential combination treatment for colorectalcancer CRC TaberneroJosep Javier_RosMD
E.E. has received personal speaker honoraria from Organon and Novartis; and personal advisory board honoraria from Amgen, Bayer, Hoffman-La Roche, Merck Serono, Sanofi, Pierre Fabre, MSD, and Servier. Educational collaboration with Imedex/HMP and PeerView Institute for Medical Education. J.R. has received personal speaker honoraria from Sanofi and AMGEN, and accommodation expenses from Pierre-Fabre, Servier, Amgen and Merck. J.T.
Hoffmann-La Roche Ltd, Genentech Inc, HalioDX SAS, Hutchison MediPharma International, Ikena Oncology, Inspirna Inc, IQVIA, Lilly, Menarini, Merck Serono, Merus, MSD, Mirati, Neophore, Novartis, Ona Therapeutics, Orion Biotechnology, Peptomyc, Pfizer, Pierre Fabre, Samsung Bioepis, Sanofi, Scandion Oncology, Scorpion Therapeutics, Seattle Genetics, Servier, Sotio Biotech, Taiho, Tessa Therapeutics and TheraMyc.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Lightning Strikes Create a Strange Form of Crystal Rarely Seen in NatureThe violent fingers of electricity that struck a sand dune in Nebraska have left behind a configuration of crystal rarely found in nature.
Read more »
Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer - Nature MedicineFederated learning improves prediction of the histological response to neoadjuvant chemotherapy in patients with triple-negative breast cancer, demonstrating the feasibility of this approach for analysis of multicenter cohorts of patients with rare diseases.
Read more »
Nature - Stops making senseWhen genes are read by ribosomes, stop codons act as punctuation, telling the ribosome when to halt protein synthesis. But in some protozoa, the base...
Read more »
Etoposide promotes DNA loop trapping and barrier formation by topoisomerase II - Nature Chemical BiologyUsing single-molecule biophysics methods, Le et al. discovered that etoposide, a chemotherapeutic poison of topoisomerase II (topo II), promotes topo II to compact DNA, trap DNA loops and pause DNA supercoiling relaxation, thus converting topo II into a strong roadblock to DNA processing.
Read more »
Drug for delaying diabetes wins landmark approval - Nature BiotechnologyThe November approval of Tzield (teplizumab) marks a turning point in the management of type 1 diabetes.
Read more »
Genomic autopsy to identify underlying causes of pregnancy loss and perinatal death - Nature MedicineIn a new study including 200 families who had experienced perinatal death, adding genomic analyses to standard autopsies improves the identification of underlying pathogenic causes and informs GeneticCounseling.
Read more »